we are a company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with a technology-based healthcare business domiciled in israel, or that carries out a substantial portion of its activities in israel, or that has some other significant israeli connection
Company profile
Ticker
CCTS
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
981598362
CCTS stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
16 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 May 24
SC 14F1/A
Statement regarding change in majority of directors (amended)
6 May 24
SC 14F1
Statement regarding change in majority of directors
6 May 24
10-K
2023 FY
Annual report
15 Apr 24
8-K
Departure of Directors or Certain Officers
12 Apr 24
8-K
Regulation FD Disclosure
2 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
SC 14F1
Statement regarding change in majority of directors
29 Mar 24
Latest ownership filings
3/A
Emmanuel Meyer
17 May 24
3/A
Pirone Rafael Meyer
17 May 24
SC 13D/A
EVGI Ltd
17 May 24
3/A
Initial statement of insider ownership (amended)
17 May 24
3
Gary Challinor
25 Apr 24
SC 13D/A
EVGI Ltd
16 Apr 24
3/A
Huiyan Geng
12 Apr 24
3/A
Joseph Cornelius Thomassen
12 Apr 24
3/A
Emmanuel Meyer
12 Apr 24
3/A
Initial statement of insider ownership (amended)
12 Apr 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.52 mm | 21.52 mm | 21.52 mm | 21.52 mm | 21.52 mm | 21.52 mm |
Cash burn (monthly) | (no burn) | 9.24 mm | 80.00 k | 155.02 k | 204.67 k | (no burn) |
Cash used (since last report) | n/a | 14.70 mm | 127.25 k | 246.57 k | 325.54 k | n/a |
Cash remaining | n/a | 6.82 mm | 21.39 mm | 21.27 mm | 21.19 mm | n/a |
Runway (months of cash) | n/a | 0.7 | 267.3 | 137.2 | 103.5 | n/a |
Institutional ownership, Q4 2023
62.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 34 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 3.16 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Cactus Healthcare Management | 3.16 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Feb 24 | Cactus Healthcare Management | Class A ordinary shares | Sell | Dispose S | No | No | 0 | 2,530,000 | 0.00 | 632,501 |
23 Feb 24 | Cactus Healthcare Management | Warrants to purchase Class A ordinary shares Class A ordinary shares | Sell | Dispose S | No | No | 11.5 | 3,893,334 | 44.77 mm | 973,333 |